Metabolic Intermediates in Tumorigenesis and Progression

Abstract

Traditional antitumor drugs inhibit the proliferation and metastasis of tumour cells by restraining the replication and expression of DNA. These drugs are usually highly cytotoxic. They kill tumour cells while also cause damage to normal cells at the same time, especially the hematopoietic cells that divide vigorously. Patients are exposed to other serious situations such as a severe infection caused by a decrease in the number of white blood cells. Energy metabolism is an essential process for the survival of all cells, but differs greatly between normal cells and tumour cells in metabolic pathways and metabolic intermediates. Whether this difference could be used as new therapeutic target while reducing damage to normal tissues is the topic of this paper. In this paper, we introduce five major metabolic intermediates in detail, including acetyl-CoA, SAM, FAD, NAD + and THF. Their contents and functions in tumour cells and normal cells are significantly different. And the possible regulatory mechanisms that lead to these differences are proposed carefully. It is hoped that the key enzymes in these regulatory pathways could be used as new targets for tumour therapy.

S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens

“…According to The National Comprehensive Cancer Network (NCCN) Distress Management Panel, "distress" can be synthesized as "an unpleasant psychological, social, and/ or spiritual experience that may weaken the ability to face up to cancer and its context". Actually, as further reported by Carlson et al [32], almost half of the patients indicate fatigue as the main problem of suffering [4,20,32]. This is also consistent with other studies [33][34][35][36].…”

“…Its protective effects both at cellular and systemic level in various chronic liver disorders, linked to oxidative stress or metabolic alterations Chemotherapy 2021;66:161-168 DOI: 10.1159/000517376 due to environmental or immune stressors, have already been demonstrated, thanks to its various cellular metabolic targets, including the prevention of reduced glutathione depletion, the main liver protective agent from reactive oxygen species [18]. Indeed, as explained in some fundamental works on the role of this molecule, such as those of Mato et al [18], Lu [19], and He et al [20], it participates in maintaining the integrity of the cell membrane by acting in transulfuration pathways and transmethylation reactions, as well as in aminopropylation for polyamine synthesis, and has an important role in the prevention of oxidative stress, thanks to its involvement in the formation of reduced glutathione [21].…”

Early lung cancer diagnostic biomarker discovery by machine learning methods

“…Cancer progression is strongly related to cellular metabolism, and the dysregulated metabolism is conducive to tumor progression and initiation [52] . Cancer cells change their metabolic pathways, which request specific enzymes to catalyze biochemical reactions, to meet the growing need of the rapid cell reproduction and division.…”

Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer

“…Amino acids play essential roles in protein synthesis, which promotes cell growth and proliferation in both normal cells and cancer cells [1][2][3][4]. Nonessential amino acids are synthesized from essential amino acids; however, essential amino acids cannot be synthesized de novo.…”